Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00642681

Enrollment

Registered

2008-03-25

Start date

2007-12-31

Completion date

2008-08-31

Last updated

2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Upper Respiratory Infection

Brief summary

Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

Interventions

DRUGTechnosphere Insulin

Technosphere® Insulin (TI) Inhalation Powder, prandial

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Subjects will have met the same inclusion criteria as MKC-TI-030 * Clinical diagnosis of URI with in 24 hrs prior to clinic visit and/or day of clinic visit * At least 3 URI symptoms

Exclusion criteria

* Prior participation in MKC-TI-112 * MedHist, PE or lab findings of acute bacterial infection including but not limited to sputum prod., nasal/eye discharge, chest exam abnormalities, CXR findings of pneumonia.

Design outcomes

Primary

Measure	Time frame
To measure Serum FDKP AUC	4 Hours

Countries

Canada, Russia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026